首页> 外国专利> Isolated anti-prostate stem cell antigen (PSCA) antibodies that internalise upon binding to PSCA on a mammalian cell, including a PSCA-expressing tumour cell, in vivo

Isolated anti-prostate stem cell antigen (PSCA) antibodies that internalise upon binding to PSCA on a mammalian cell, including a PSCA-expressing tumour cell, in vivo

机译:分离的抗前列腺干细胞抗原(PSCA)抗体在体内与哺乳动物细胞(包括表达PSCA的肿瘤细胞)结合后会内在化

摘要

Described are isolated anti-prostate stem cell antigen (PSCA) antibodies that internalize upon binding to PSCA on a mammalian in vivo. Compositions comprising an anti-PSCA antibody and a carrier are also provided. These compositions can be contained in an article of manufacture or a kit. Another aspect described is an isolated nucleic acid encoding an anti-PSCA antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-PSCA antibodies, and a method of producing the anti-PSCA antibodies. Other aspects include a method of killing a PSCA-expressing cancer cell, comprising contacting the cancer cell with an anti-PSCA antibody and a method of alleviating or treating a PSCA-expressing cancer in a non-human mammal, comprising administering a therapeutically effective amount of the anti-PSCA antibody to the mammal.
机译:描述了分离的抗前列腺干细胞抗原(PSCA)抗体,其与哺乳动物体内的PSCA结合后内在化。还提供了包含抗PSCA抗体和载体的组合物。这些组合物可以包含在制品或试剂盒中。所描述的另一方面是编码抗PSCA抗体的分离的核酸,以及包含该分离的核酸的表达载体。还提供了产生抗PSCA抗体的细胞,以及产生抗PSCA抗体的方法。其他方面包括杀死表达PSCA的癌细胞的方法,该方法包括使癌细胞与抗PSCA抗体接触,以及在非人类哺乳动物中减轻或治疗表达PSCA的癌症的方法,包括给予治疗有效量。对哺乳动物的抗PSCA抗体的制备。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号